ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "T cells"

  • 2016 American Transplant Congress

    Combination of Veto Cell Transfer and iNKT Cell Therapy Establishes Complete Hematopoietic Chimerism in Non-Myeloablative BMT Recipients.

    R. Ishii,1 T. Hirai,1 Y. Ishii,2 K. Tanabe.1

    1Department of Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Laboratory for Vaccine Design, RIKEN IMS-RCAI, Yokohama, Japan.

    Hematopoietic chimerism after non-myeloablative bone marrow transplantation (nmBMT) has been found beneficial for establishment of transplant tolerance. Since bone marrow cells (BMCs) are endowed with…
  • 2016 American Transplant Congress

    Kidney Allotransplantation Induces the Differentiation of Antigen-Experienced CD8 T Cells with Enhanced Metabolic Profiles.

    G. Tilly,1,2 M. Yap,1,2 M. Giral,1,2,3 S. Brouard,1,3 C. Pecqueur,4 N. Degauque.1,3

    1UMR 1064, INSERM, Nantes, France; 2Université de Nantes, Nantes, France; 3ITUN, CHU de Nantes, Nantes, France; 4UMR 892, INSERM, Nantes, France.

    Background. Naïve and memory CD8 T cells have been shown to exhibit different metabolic profiles, especially upon antigen stimulation. However, it is unknown whether the…
  • 2016 American Transplant Congress

    Quantiferon-CMV Test, CMV-Specific ELISPOT and CMV-Dextramer Assays in Assessing the Risk of CMV Infection in Seropositive Kidney Transplant Recipients.

    H. Lee,1 K. Park,2 J. Ryu,2 J. Yu,3 B. Chung,3 C. Yang,3 E.-J. Oh.1

    1Department of Laboratory Medicine, The Catholic University of Korea, Seoul, Korea; 2Department of Biomedical Science, Graduate School, The Catholic University of Korea, Seoul, Korea; 3Division of Nephrology, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea.

    Human cytomegalovirus (CMV) infection is one of the primary opportunistic pathogens and is a leading cause of morbidity and mortality in kidney transplant recipients. Assessing…
  • 2016 American Transplant Congress

    Banked EBV-Specific T-Cells for Treatment of Rituximab Refractory EBV+ B-Cell Lymphoma in Solid Organ Transplantation Recipients.

    S. Prockop,1 E. Doubrovina,1 C. Sauter,2 S. Suser,1 R. O'Reilly.1

    1MKSCC, New York, NY; 2MSKCC, New York, NY.

    Morbidity and mortality from EBV-induced post-transplant lymphoproliferative disease (EBV+ PTLD) can complicate solid organ transplant (SOT), particularly in those seronegative prior to transplant and in…
  • 2016 American Transplant Congress

    Foxp3 Controls Oxidative Phosphorylation in Regulatory T Cells.

    U. Beier,1 A. Angelin,2 J. Jiao,1 H. Xiao,1 L. Wang,3 S. Dahiya,3 A. Wells,3 D. Wallace,2 W. Hancock.3

    1Pediatric Nephrology, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA; 2Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia, Philadelphia, PA; 3Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia and University of Pennsylvania, Philadelphia, PA.

    Current immunosuppressive therapies are limited by non-specificity and toxicities, and new pharmacologic approaches to immunosuppressive therapies are needed. Many T cell subsets have distinct metabolic…
  • 2016 American Transplant Congress

    Administration of IL-33 Before Allogeneic Stem Cell Transplantation Expands Recipient Treg That Prevent Graft- vs. Host Disease.

    B. Matta,1 D. Reichenbach,2 X. Zhang,1 B. Koehn,2 L. Mathews,1 C. Feser,2 M. Smith,2 Q. Liu,1 R. Zeiser,3 B. Blazar,2 H. Turnquist.1

    1Dept of Surgery and Starzl Transplant Inst, Univ of Pittsburgh Sch of Med, Pittsburgh, PA; 2Dept of Pediatrics, Univ of Minnesota, Minneapolis, MN; 3Univ Med Cntr Freiburg, Freiburgh, Germany.

    Background: During allogeneic hematopoietic cell transplantation (alloHCT), non-hematopoietic cell IL-33 is augmented and released by recipient conditioning to promote Type 1 alloimmunity and lethal acute…
  • 2015 American Transplant Congress

    The Significant Association Between the Functional Polymorphism (Rs3761548) of Foxp3 Gene and the Severity of Acute Cellular Rejection in Liver Transplantation

    S. Verma, Y. Tanaka, S. Shimizu, L. Das, H. Ohdan.

    Department of Gastroenterological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    Aim- Acute cellular rejection (ACR) accounts for 15-25% of graft failure in living donor liver transplantation (LDLT). T regulatory cells (Treg) play an important role…
  • 2015 American Transplant Congress

    Aging Enhances Immunosuppressives Capacities of Tacrolimus By Functional Changes of CD4+ T-Cells

    F. Krenzien,1 M. Quante,1 A. ElKhal,1 H. Uehara,1 R. Abdi,2 B. Slegtenhorst,1 H. Biefer,1 S. Tullius.1

    1Transplant Surgery Research Laboratory and Division of Transplant Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; 2Transplantation Research Center, Renal Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.

    Immunosenescence has broad consequences on alloimmunity and immunosuppression in the elderly may require age-adaptation. Here, we investigated the influence of aging on the effectivity of…
  • 2015 American Transplant Congress

    Characterization of Natural T Effector Memory Cells Specific for Collagen type V, k-α-1-Tubulin and Vimentin

    J. Sullivan,1 D. Wilkes,2 T. Mohanakumar,3 W. Burlingham.1

    1Surgery, University of Wisconsin, Madison, WI; 2Medicine, Indiana University, Indianapolis, IN; 3Surgery, Washington University, St. Louis, MO.

    Background: Injury and repair processes are highly controlled, common occurrences of healthy tissue remodeling. During this process, cellular antigens that are not normally exposed to…
  • 2015 American Transplant Congress

    Identification of CXCR5+EBV-Specific CD8+ T Cells in Peripheral Blood of Pediatric Heart Transplant Recipients Correlates With IL-21 Production and EBV Reactivation

    C. Macedo,1 K. Hadi,1 D. Rowe,2 J. Luce,3 S. Webber,4 B. Feingold,3 D. Metes.1

    1Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh; 2Infectious Diseases and Microbiology, University of Pittsburgh, Pittsburgh; 3Pediatrics-Cardiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh; 4Pediatrics, Vanderbilt University School of Medicine, Nashville.

    Approximately 70% of EBV asymptomatic pediatric heart transplant (HTx) recipients carry chronic EBV loads in peripheral blood. These EBV loads may occur due to impaired…
  • « Previous Page
  • 1
  • …
  • 45
  • 46
  • 47
  • 48
  • 49
  • …
  • 53
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences